TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy

Hepatology

Volumn 35, Issue 1, 2002, Pages 132-139

  Perelló, Antonia ^a   García Pagán, Juan Carlos ^a   Gilabert, Rosa ^a   Suárez, Yanette ^a   Moitinho, Eduardo ^a   Cervantes, Francisco ^a   Reverter, Juan Carlos ^a   Escorsell, Angels ^a   Bosch, Jaume ^a   Rodés, Juan ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BUDD CHIARI SYNDROME; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; MALE; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME;

EID: 18244366658     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.30274     Document Type: Article

References (43)

1. Budd-Chiari syndrome: Etiology, diagnosis and management
2. Budd-Chiari syndrome. Treatment options and the value of liver transplantation
3. Clinical events after transjugular intrahepatic portosystemic shunt: Correlation with hemodynamic findings
4. Transjugular intrahepatic portosystemic stent-shunt (TIPS) in the treatment of Budd-Chiari syndrome
5. Budd-Chiari syndrome: Technical, hemodynamic, and clinical results of treatment with transjugular intrahepatic portosystemic shunt
6. Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: Review of indications and problems
7. Budd-Chiari syndrome, portal vein and mesenteric vein thrombosis in a patient homozygous for factor V Leiden mutation treated by TIPS and thrombolysis
8. Successful treatment of chronic Budd-Chiari syndrome with a transjugular intrahepatic portosystemic shunt
9. Treatment of Budd-Chiari syndrome with a transjugular intrahepatic portosystemic shunt
10. Role of TIPS as a bridge to hepatic transplantation in Budd-Chiari syndrome
11. Use of transjugular intrahepatic portosystemic shunt as a bridge to transplantation in fulminant hepatic failure due to BuddChiari syndrome
12. Acute Budd-Chiari syndrome: Treatment with transjugular intrahepatic portosystemic shunt
13. Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome
14. A case of Budd-Chiari syndrome successfully treated by transcatheter recanalization of the right hepatic vein and transjugular intrahepatic portosystemic shunt
15. Treatment of Budd-Chiari syndrome with portosystemic shunt or liver transplantation
16. A 27-year experience with surgical treatment of Budd-Chiari syndrome
17. Which is the best surgery for Budd-Chiari syndrome: Venous decompression or liver transplantation? A single-center experience with 50 patients
18. Outcome of Budd-Chiari syndrome: A multivariate analysis of factors related to survival including surgical portosystemic shunting
19. The diagnostic criteria of polycythaemia rubra vera
20. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: A final report on diagnostic criteria, survival, and leukemic transition by treatment
21. Myelofibrosis with myeloid metaplasia in young individuals: Disease characteristics, prognostic factors and identification of risk groups
22. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
23. Criteria for the diagnosis of lupus anticoagulants: An update. On behalf of the subcommittee on lupus anticoagulant/antiphospholipid antibody of the scientific and standardisation committee of the ISTH
24. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: Results of a case-control study
25. Transjugular intrahepatic portosystemic stent-shunt (TIPSS) occlusion and the role of biliary venous fistulae
26. BuddChiari syndrome with long segmental inferior vena cava obstruction: Treatment with thrombolysis, angioplasty, and intravascular stents
27. Thrombolysis for acute BuddChiari syndrome: Case report and literature review
28. Budd-Chiari syndrome in patients with hematological disease: A therapeutic challenge
29. The Budd-Chiari syndrome. Medical and surgical management of 30 patients
30. Selective surgical therapy of the Budd-Chiari syndrome provides superior survivor rates than conservative medical management
31. Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factors
32. Portasystemic shunting versus liver transplantation for the Budd-Chiari syndrome
33. Mesoatrial shunt in Budd-Chiari syndrome
34. Current management of the Budd-Chiari syndrome
35. Long-term results of treatment of Budd-Chiari syndrome with portal decompression
36. Treatment of Budd-Chiari syndrome by side-to-side portacaval shunt: Experimental and clinical results
37. Portosystemic shunt in Budd-Chiari syndrome: Long-term survival and factors affecting shunt patency in 25 patients in Western countries
38. Diagnosis and management of the BuddChiari syndrome
39. Two-step procedure in Budd-Chiari syndrome with severe intrahepatic vena cava stenosis: Vena cava stenting and portocaval shunt
40. Dilatation of the inferior vena cava using an expandable metal stent in Budd-Chiari syndrome
41. The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): State of the art
42. The changing scene of hepatic vein thrombosis: Recognition of asymptomatic cases
43. Fulminant hepatic failure from the Budd-Chiari syndrome. A bridge to transplantation with transjugular intrahepatic portosystemic shunt